Inigo Angulo-Barturen

Inigo Angulo-Barturen

UNVERIFIED PROFILE

Are you Inigo Angulo-Barturen?   Register this Author

Register author
Inigo Angulo-Barturen

Inigo Angulo-Barturen

Publications by authors named "Inigo Angulo-Barturen"

Are you Inigo Angulo-Barturen?   Register this Author

66Publications

4110Reads

14Profile Views

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.

Proc Natl Acad Sci U S A 2019 04 20;116(14):7015-7020. Epub 2019 Mar 20.

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom;

View Article

Download full-text PDF

Source
http://www.pnas.org/lookup/doi/10.1073/pnas.1814685116
Publisher Site
http://dx.doi.org/10.1073/pnas.1814685116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452685PMC
April 2019

Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection.

Antimicrob Agents Chemother 2015 Aug 18;59(8):4997-9. Epub 2015 May 18.

Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain Open Collaborative Model for Tuberculosis Lead Optimisation (ORCHID) Consortium‡

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01063-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505286PMC
August 2015

Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy.

J Control Release 2015 Jul 23;210:217-29. Epub 2015 May 23.

Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), Baldiri Reixac 10-12, ES-08028 Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain; Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Martí i Franquès 1, ES-08028 Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01683659150058
Publisher Site
http://dx.doi.org/10.1016/j.jconrel.2015.05.284DOI Listing
July 2015

Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia.

J Infect Dis 2015 Jun;211 Suppl 3:S96-S106

Tres Cantos Medicines Development Campus, Diseases of the Developing World, GlaxoSmithKline, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiu610DOI Listing
June 2015

Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination.

Clin Vaccine Immunol 2014 Apr 5;21(4):594-7. Epub 2014 Feb 5.

Grupo de Genética de Micobacterias, Departmento de Microbiología, Medicina Preventiva y Salud Pública, Faculty of Medicine, Universidad de Zaragoza, Zaragoza, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/CVI.00700-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993116PMC
April 2014

Animal models of efficacy to accelerate drug discovery in malaria.

Parasitology 2014 Jan 21;141(1):93-103. Epub 2013 Jun 21.

GlaxoSmithKline, Diseases of the Developing World-Tres Cantos Medicines Development Campus, Tres Cantos 28760, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0031182013000991DOI Listing
January 2014

Humanised models of infection in the evaluation of anti-malarial drugs.

Drug Discov Today Technol 2013 Sep;10(3):e351-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ddtec.2012.07.003DOI Listing
September 2013

Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.

Future Med Chem 2012 Dec;4(18):2311-23

GlaxoSmithKline, Tres Cantos Medicines Development Campus, Diseases of the Developing World. C/ Severo Ochoa, 2, 28760-Tres Cantos, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc.12.177DOI Listing
December 2012

Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.

Tuberculosis (Edinb) 2012 Nov 30;92(6):453-88. Epub 2012 Aug 30.

Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 S Wood Street, Chicago, IL 60621-7231, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147297921200140
Publisher Site
http://dx.doi.org/10.1016/j.tube.2012.07.003DOI Listing
November 2012

Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.

Antimicrob Agents Chemother 2010 May 16;54(5):2262-4. Epub 2010 Feb 16.

GlaxoSmithKline, Infectious Diseases Centre of Excellence in Drug Discovery, Diseases of the Developing World, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01423-09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2863680PMC
May 2010